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perturbs biofilm formation and fimbriae expres-
sion in Klebsiella pneumoniae MGH 78578
Tzu-Wen Huang1,2, Irene Lam2, Hwan-You Chang3, Shih-Feng Tsai1, Bernhard O Palsson2 and Pep Charusanti2*Abstract
Background: Klebsiella pneumoniae is a leading cause of hospital-acquired urinary tract infections and pneumonia
worldwide, and is responsible for many cases of pyogenic liver abscess among diabetic patients in Asia. A defining
characteristic of this pathogen is the presence of a thick, exterior capsule that has been reported to play a role in
biofilm formation and to protect the organism from threats such antibiotics and host immune challenge.
Findings: We constructed two knockout mutants of K. pneumoniae to investigate how perturbations to capsule
biosynthesis alter the cellular phenotype. In the first mutant, we deleted the entire gene cluster responsible for
biosynthesis of the extracellular polysaccharide capsule. In the second mutant, we deleted the capsule export
subsystem within this cluster. We find that both knockout mutants have lower amounts of capsule but produce
greater amounts of biofilm. Moreover, one of the two mutants abolishes fimbriae expression as well.
Conclusions: These results are expected to provide insight into the interaction between capsule biosynthesis,
biofilm formation, and fimbriae expression in this organism.
Keywords: Klebsiella pneumoniae, Capsule, Biofilm, Fimbriae, Expression profiling, Gene knockouts, Transmission
electron microscopy, Infectious diseaseFindings
Introduction
Klebsiella pneumoniae is a Gram-negative bacterium
that is a member of the family Enterobacteriaceae and is
closely related phylogenetically to the genera Escheri-
chia, Salmonella, Shigella, and Yersinia. Medically, K.
pneumoniae causes a wide range of diseases worldwide
such pneumonia, urinary tract infections, and surgical
wound infections that primarily afflict immunocom-
promised patients in hospital settings and long-term
care facilities. The number of community-acquired in-
fections caused by K. pneumoniae, however, has in-
creased worldwide over the past several decades. For
example, invasive forms of the disease characterized by
bacteremic liver abscesses or endophthalmitis that are
contracted in the community are endemic in Asia [1-3],
especially in Taiwan [4-7], and reports of their* Correspondence: pcharusanti@ucsd.edu
2Department of Bioengineering, University of California, San Diego La Jolla,
CA, 92093-0412 USA
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reproduction in any medium, provided the oroccurrence are now emerging in other parts of the world
[8,9]. Infections caused by K. pneumoniae can be diffi-
cult to treat since many clinical isolates possess an ex-
tensive repertoire of antibiotic resistance genes.
Ominously, some strains have now been isolated from
different parts of the world that harbor New Delhi
metallo-β-lactamase 1 (NDM-1) [10,11], a gene that con-
fers resistance to carbapenem antibiotics, the last-line
treatment option against most K. pneumoniae infections.
Compounding the medical threat is the paucity of new
antibiotics that are being developed against multi-drug
resistant Gram-negative bacteria such as K. pneumoniae.
Despite its close relationship to other enterobacteria,
one notable difference between K. pneumoniae and
other members of this family is the presence of an ex-
tremely thick, hypermucoviscous, extracellular polysac-
charide capsule that surrounds this bacterium. At least
77 distinct capsular serotypes have been reported to date
[12], but virulent strains have been predominantly asso-
ciated with the K1 and K2 serotypes, in particular K1
[12-15]. The genes responsible for biosynthesis of theLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 List of strains and plasmids used in this study
Strains/
Plasmids
Description Source
K. pneumoniae strains
MGH 78578 Clinical isolate from a pneumonia
patient. Parental (wild-type) strain for
gene deletion.
ATCC
Δwzabc In-frame deletion of wzabc operon
(KPN_02510-KPN_02512)
This study
Δcps In-frame deletion of capsule biosynthesis
cluster ranging from ugd (KPN_02493) to
galF (KPN_02515)
This study
E. coli strains
Top10 Competent cells for general cloning Life
Technologies
Plasmids
pACBSR A p15A replicon plasmid containing an
arabinose-inducible λ-Red recombinase
and chloramphenicol resistance selection
marker
[25]
pEXP5-CT General vector containing ampicillin
resistance used during sub-cloning to
make pACBSR-Hyg
Life
Technologies
pSecTag/
FRT/V5-His
Vector containing a promoter-less
hygromycin resistance gene
Life
Technologies
pEXP5-CT-
hyg
Same as pEXP5-CT, but with the ampicillin
resistance marker replaced with a hygro-
mycin resistance marker
This study
pCP20 Plasmid bearing a heat-shock inducible
FLP recombinase
[26]
pIJ773 Template for amplification of the
apramycin resistance cassette
[27]
pACBSR-
Hyg
Same as pACBSR, but with the
chloramphenicol resistance marker
replaced with a hygromycin resistance
marker
This study
pFLP-Hyg Same as pCP20, but with the pSC101
replicon and chloramphenicol resistance
marker of pCP20 replaced with the p15A
replicon and hygromycin resistance
marker from pACBSR-Hyg
This study
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http://www.biomedcentral.com/1756-0500/7/13capsule are normally located in a cluster that is 21 to
30 kb in length and comprise 16 to 25 ORFs [16]. The
capsule is believed to be a major virulence determinant
by protecting K. pneumoniae from phagocytosis [17-19]
and destruction by antimicrobial peptides [20]. Further-
more, the capsule is thought to play a crucial role in bio-
film formation, which allows the organism to colonize
indwelling medical devices and better survive hostile
conditions such as detergents aimed at removing the
biofilms, since mutants of K. pneumoniae strain LM21
with disruptions in different genes involved in capsule
biosynthesis produce less biofilm [21]. Consistent with
these findings, a separate signature-tagged mutagenesis
study also identified a mutation in ORF12 of the K.
pneumoniae strain 43816 K2 capsule gene cluster that
resulted in less biofilm formation [22]. On the other
hand, a third study found that a non-encapsulated de-
rivative of K. pneumoniae strain C105 produced greater
amounts of biofilm than the parental strain, and corre-
lated this observation to the expression of type 1 fim-
briae [23]. A fourth study found that type 3 fimbriae
promoted biofilm formation in a strain that still pos-
sessed its capsule [24].
These findings in aggregate highlight the complex
interaction between capsule biosynthesis, biofilm forma-
tion, and fimbriae expression. Against this backdrop, we
investigated the relationship among encapsulation, bio-
film formation, and fimbriae expression in K. pneumo-
niae strain MGH 78578. Significantly, we found that a
non-encapsulated mutant produced larger amounts of
biofilm as has been reported [23], but in contrast also
found that no fimbriae was required for this phenotype.
Materials and methods
Strains and primers
Klebsiella pneumoniae strain MGH 78578 was pur-
chased from ATCC. All other strains were generated as
part of this study (Table 1). All primers for plasmid
construction and gene knockouts can be found in
Additional file 1.
Growth media
All experiments were conducted using bacteria grown in
LB, low salt LB, or glucose M9 media. Low salt LB con-
sisted of (per liter) 5 g yeast extract, 10 g tryptone, and
5 g NaCl, and was adjusted to pH 8.0 with NaOH.
Glucose M9 was composed of the following chemicals
(per liter): 6.8 g Na2HPO4; 3 g KH2PO4; 0.5 g NaCl; 1 g
NH4Cl; 100 μM CaCl2; 2 mM MgSO4; 2 g dextrose.
Stock solutions of CaCl2, MgSO4, and dextrose were fil-
ter sterilized through Millipore ExpressPlus 0.22 μm
membranes (Millipore, Billerica, MA) and subsequently
added individually to autoclaved solutions containing
the first four chemicals. Hygromycin (Sigma-Aldrich,St. Louis, MO) and apramycin (Research Products Inter-
national, Mt. Prospect, IL) were added to the media to
final concentrations of 100 μg/ml and 50 μg/ml, respect-
ively, as necessary. Low salt LB and hygromycin are al-
ways used together; all other steps use standard LB.
Construction of knockout mutants
A detailed description of the knockout procedure and
plasmid maps can be found in Additional file 2. A simi-
lar protocol was recently published [28].
Capsule quantification
The capsule surrounding K. pneumoniae MGH 78578
belongs to the K52 serotype, which has a hexasaccharide
repeating unit composed of two rhamnose, one glucose,
Figure 1 Construction of two capsule defective mutants, Δcps and Δwzabc. A. Genetic loci that were deleted in the two mutants Δwzabc
and Δcps. A portion of the capsule export system within the capsule biosynthesis cluster was deleted in Δwzabc whereas the entire biosynthesis
cluster was deleted in Δcps. The deletions in both mutants left behind an 81 bp scar region (red box). The triangles indicate the CDSs inside the
gene clusters. B. Gel image confirming the deletions in both mutants. Two primer pairs (1 and 2 for Δwzabc; 3 and 4 for Δcps) were used to
verify the deletions by PCR. The small arrows in part A denote the approximate binding location of the primers used to generate these
amplicons. Pairs 1 and 3 were designed to amplify the 5′ and 3′ junctions of the wild-type sequence, respectively, while pairs 2 and 4 were de-
signed such that either the forward or reverse primer from each pair bound inside the scar region. In this way, pairs 1 and 3 will produce a PCR
amplicon if the wild-type sequence is still present, whereas pairs 2 and 4 amplify only if the correct target locus has been deleted. The amplicon
sizes are: pair 1, 833 bp; pair 2, 741 bp; pair 3; 602 bp; pair 4, 428 bp.
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surements of the amount of capsule surrounding wild-
type K. pneumoniae MGH 78578 and all the mutants
were based on the protocol of Domenico, et al. [30].Transcriptome profiling
For transcriptome profiling, a high-density oligonucleo-
tide tiling array consisting of 379,528 50-mer probes
spaced 30 bp apart across the whole K. pneumoniae
MGH 78578 genome was custom-designed by Nimble-
Gen (Roche). Total RNA from OD600 ~0.5 cultures were
hybridized to the arrays according to the protocol of
Qiu, et al. [31]. The normalized probe level information
was transformed into expression level data for each gene
using the Genbank annotation for K. pneumoniae MGH
78578 (accession number PRJNA57619). Genes were
deemed differentially expressed between the two mu-
tants and the wild-type if there was a 2-fold or greater
change and they had a p-value less than 0.05. The ex-
pression profiling datasets of K. pneumoniae wild-type
and capsule deletion mutant (Δcps) have been deposited
in the Gene Expression Omnibus (GEO) database and
assigned the accession number GSE40011. Three bio-
logical replicates of the wild-type, Δcps, and Δwzabc
strains were used to generate the array data.Transmission electron microscopy imaging
The samples were negatively stained with 1% aqueous
uranyl acetate and examined on an FEI Tecnai G2
Sphera transmission electron microscope at 200 keV.
Images were recorded on a Gatan Ultrascan UHS CCD
camera.
Results and discussion
Deletion of the entire capsule biosynthesis cluster and the
export subsystem leads to phenotypic defects in the two
mutants
We developed a gene knockout procedure for K. pneu-
moniae that is based on the widely-used E. coli λ-Red re-
combinase system. The independent development of a
similar protocol was recently reported [28]. The method
developed here requires two selection markers, one
(apramycin resistance) is used to replace the target gene
and the other (hygromycin resistance) selects for two
plasmids used at different times to mediate homologous
recombination and excision of the apramycin resistance
cassette.
We examined how different homology lengths affect
transformation efficiency by deleting the same locus in
K. pneumoniae using cassettes that contained 39-bp, 60-
bp, and 700-bp homology to the target region. This tar-
get region was the three genes (wza, wzb, and wzc) that
Figure 2 Phenotypic characterization of both capsule deletion
mutants. A. Growth curves for the wild-type (WT), Δwzabc, and
Δcps strains. B. Measurements of uronic acid content in the
wild-type, Δwzabc, and Δcps strains. Values were normalized by the
optical densities of the samples when the measurements were
made. C. The susceptibility of the wild-type, Δwzabc, and Δcps
strains to hydrogen peroxide (left) and polymyxin B (right). Error bars
in all three panels denote the standard deviation of three
biological replicates.
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each of the three PCR products was electroporated into
the host. We recovered 26, 46, and 255 apramycin-
resistant transformants using the 39-bp, 60-bp, and 700-
bp homology lengths, resulting in transformation
efficiencies of 1.3 × 10-8, 2.5 × 10-8, and 1.1 × 10-7, re-
spectively. To confirm these mutant candidates, we next
examined 24 colonies from each group by PCR. None of
the 24 colonies from the 39-bp group was a correct
knockout mutant, whereas two colonies from the 60-bp
group and ten colonies from the 700-bp group were cor-
rect (data not shown). Although longer homology
lengths resulted in higher transformation efficiency,
these results implied that replacement cassettes contain-
ing 60-bp homology were sufficient to create knockout
mutants. The construction of such cassettes requires
DNA oligos that are only 80–85 nucleotides long, which
can be readily purchased from commercial vendors. The
use of knockout cassettes bearing longer homology arms
would require an additional cloning step. For these rea-
sons, we constructed all knockout mutants in this study
using 60-bp homology.
We deployed our knockout protocol to investigate
how the deletion of genes involved in biosynthesis of the
thick, extracellular polysaccharide capsule surrounding
K. pneumoniae perturbs the bacterium. We constructed
two knockout mutants (Figure 1): the entire capsule bio-
synthesis cluster was deleted in one mutant, Δcps,
whereas three genes responsible for capsule export (the
wza-b-c operon) were deleted in the other mutant,
Δwzabc (Table 1) [32,33]. Both deletions are marker-
free, and we confirmed that the wild-type allele was
completely absent in the two mutants by PCR and
Sanger sequencing (Figure 1B).
The growth rates of the wild-type and Δcps strains during
batch culture in glucose M9 were 1.022 ± 0.0028 and 0.808
± 0.0057 (1/hour), respectively, indicating a statistically sig-
nificant decrease in the growth rate (P < 5 × 10-6, Student’s
t-test) (Figure 2A). Growth rates were calculated from
time-course OD600 measurements. The Δwzabc mutant
showed a biphasic growth pattern in which the growth rate
during the first four hours was identical to that of the wild-
type (1.026 ± 0.048 1/hour) but dropped to 0.49 ± 0.010
(1/hour) thereafter (Figure 2A).
Table 2 List of the 20 genes most significantly up- and down-regulated in the Δcps mutant relative to wild-type levels
Locus Gene product Expression level
(wild-type)
Expression level
(Δcps)
p-value Fold change
Up-regulated genes
KPN_00042 Hypothetical 9.00 13.38 0.0021 20.82
KPN_00321 Hypothetical 6.63 9.20 0.0007 5.92
KPN_01030 Hypothetical 8.15 10.65 0.0170 5.66
KPN_01107 Hypothetical 9.41 13.32 0.0021 15.03
KPN_01226 Periplasmic protein 10.59 13.27 0.0052 6.38
KPN_01279 Lipoprotein, osmotically inducible 11.03 13.96 0.0012 7.62
KPN_01568 Hypothetical 7.46 10.07 0.0085 6.10
KPN_01977 Lysozyme inhibitor 9.57 12.45 0.0007 7.34
KPN_02742 Hypothetical 8.95 11.38 0.0057 5.40
KPN_03160 Hypothetical 11.17 13.82 0.0028 6.30
KPN_04221 Periplasmic repressor CpxP 10.08 12.49 0.0044 5.32
KPN_04433 Putative stress-response protein 9.46 11.81 0.0083 5.09
KPN_04512a N-glycosyl-transferase PgaC 6.40 9.74 0.0003 10.13
KPN_04513a Putative polysaccharide deacetylase 6.38 9.79 0.0006 10.67
KPN_04514a Outer membrane protein PgaA 6.43 10.95 0.0002 22.95
KPN_04515a Hypothetical 6.56 12.30 0.0059 53.44
KPN_04516a Hypothetical 7.64 11.25 0.0010 12.21
KPN_04684 Putative sulfate transporter 8.78 11.67 0.0013 7.41
KPN_04685 Putative carbonic anhydrase 10.50 13.32 0.0049 7.02
KPN_04773 Putative porin 9.17 12.04 0.0026 7.31
Down-regulated genes
KPN_00464 Copper exporting ATPase 10.44 8.48 0.0024 0.26
KPN_00626 methylthioribose kinase MtnK 11.02 9.38 0.0052 0.32
KPN_00688 tRNA-Gln-CTG 13.17 11.34 0.0213 0.28
KPN_00689 tRNA-Gln-CTG 13.01 11.26 0.0287 0.30
KPN_01055 tRNA-Ser-GGA 13.00 11.11 0.0341 0.27
KPN_01427 Hypothetical 9.12 7.35 0.0040 0.29
KPN_02433 tRNA-Asn-GTT 15.01 12.52 0.0365 0.18
KPN_02448 tRNA-Asn-GTT 14.91 12.54 0.0246 0.19
KPN_02488 dTDP-4-dehydrorhamnose 3,5-epimerase 12.69 11.02 0.0032 0.31
KPN_02489 dTDP-4-dehydrorhamnose reductase 13.06 11.18 0.0035 0.27
KPN_02593 Colicin I receptor 14.38 12.83 0.0034 0.34
KPN_02746 tRNA-Ala-GGC 10.11 8.52 0.0257 0.33
KPN_02747 tRNA-Ala-GGC 10.36 8.87 0.0377 0.36
KPN_02920 Bifunctional chorismate mutase/prephenate dehydratase 11.74 10.24 0.0092 0.35
KPN_03277b Putative fimbrial usher protein 13.08 11.49 0.0024 0.33
KPN_03278b Putative pili assembly chaperone 13.66 12.05 0.0024 0.33
KPN_04263 tRNA-Trp-CCA 10.89 8.38 0.0088 0.18
KPN_04300 tRNA-Pro-TGG 9.93 8.11 0.0193 0.28
KPN_04425 Maltoporin 11.34 9.61 0.0051 0.30
KPN_04776 Carbon starvation protein 9.26 7.63 0.0043 0.32
aGenes associated with the pga operon.
bGenes associated with the mrk type 3 fimbriae operon.
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Figure 3 Transmission electron microscopy images of wild-type
K. pneumoniae and the Δwzabc and Δcps mutants. The wild-
type and Δwzabc are fimbriated, whereas Δcps is not. All images
were taken at 19,000X nominal magnification (27,290X
CCD magnification).
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cells provides an indirect measure of the amount of
extracellular capsule [34-37]. When compared to wild-
type levels, the quantity of uronic acid in the Δcps and
Δwzabc mutants declined to 0.29 ± 0.17 and 0.38 ±
0.04 fold change, respectively (P < 7.5 × 10-4 for both,
Student’s t-test) (Figure 2B). As a negative control, we
performed the same assay side-by-side using blank
media only. Absorbance measurements for these control
samples were consistently below the detection threshold
of our spectrophotometer.
We next measured the sensitivity of the wild-type,
Δcps, and Δwzabc strains to oxidative stress and the
antimicrobial peptide polymyxin B since the absence of
capsule was expected to increase sensitivity to these two
stresses. Both measurements were carried out using a
disc diffusion assay in which hydrogen peroxide or poly-
myxin B was impregnated into the disc and then placed
onto agar plates covered by a lawn of each strain. The
diameter of the inhibition zone of the wild-type and
Δwzabc mutant to hydrogen peroxide was 22.3 mm in
contrast to 26.7 mm for the Δcps mutant (P < 0.001, Stu-
dent’s t-test) (Figure 2C). Similarly, the antimicrobial
peptide polymyxin B assay produced a diameter of
19.0 mm each time when three independent tests on
Δcps were performed, but only 14 mm on wild-type and
Δwzabc (Figure 2C).
Expression profiling of the Δcps and Δwzabc deletion
mutants reveals interplay between capsule biosynthesis and
phenotypic defects
The phenotypic changes we observed in the Δcps capsule
deletion mutant motivated us to examine gene expression
differences between the Δcps and Δwzabc mutants versus
the wild-type strain. Of 112 genes up-regulated more than
two-fold (Table 2), those with the greatest fold increase
belonged to the gene cluster KPN_04512 – KPN_04515,
which is annotated as the pga operon that is responsible for
synthesis of poly-beta-1,6-N-acetyl-D-glucosamine (PGA or
poly-GlcNAc), a secreted, extracellular component of the
biofilm matrix [38]. The transcription level of the pga
operon was also slightly elevated in the Δwzabc mutant
(Additional file 3).
Eighty-nine genes were down-regulated more than two-
fold in the Δcps mutant and fell within several groups: 17
plasmid-borne genes from pKPN3 and pKPN4, 13 meta-
bolic genes, 11 tRNA genes, and eight genes associated with
type 1 and type 3 fimbriae. Of the eight fimbriae-associated
genes, five were located within the same cluster
(KPN_03274 – KPN_03278) (Additional file 3). Genbank
currently does not associate this set of genes with a specific
type of fimbriae; however, each one is 100% homologous at
the amino acid level to the mrkJFDCB cluster from K.
pneumoniae NTUH-2044 that encodes type 3 fimbriae. Wetherefore assume that this set of five genes encodes type 3
fimbriae in K. pneumoniae MGH 78578 as well. The other
three (fimA, fimI, and fimC; KPN_03287 – KPN_03289)
(Additional file 3) are located within a cluster whose gene
product is annotated to be type 1 fimbriae.Fimbriae biosynthesis is abolished in Δcps but not Δwzabc
In lieu of standard RT-PCR, we interrogated the findings
from expression analysis through a series of corresponding
phenotypic assays. The down-regulation of genes encoding
both type 1 (fim cluster) and type 3 (mrk cluster) fimbriae
raised the possibility that fimbriation had declined in the
two mutants. To investigate this possibility, we visualized
the surface structure of the wild-type and the two knockout
mutants using transmission electron microscopy (TEM).
Fimbriae could be detected on the surface of the wild-type
and Δwzabc mutant but not on the Δcps mutant (Figure 3).Up-regulation of the pga operon appears to be a more
important factor in biofilm formation than down-regulation
of the fimbriae-associated operons.
Type 1 fimbriae has been previously linked to increased
biofilm formation in a non-encapsulated K. pneumoniae
mutant [23]. In our non-encapsulated Δcps mutant,
however, we observed twice as much biofilm relative to
wild-type levels (Figure 4) but no fimbriae (Figure 3)
when using a crystal violet assay to quantify the amount
of biofilm [39]. These observations suggest that upregu-
lation of the pga operon alone is sufficient to promote
biofilm formation in non-encapsulated mutants; fimbriae
are not needed. The Δwzabc mutant produced even
greater amounts of biofilm (four-fold increase) when
compared to the wild-type (Figure 4), but the pga op-
eron was overexpressed only 1.7-fold (Additional file 3).
The continued presence of fimbriae suggests that, in this
mutant, both the pga operon and fimbriae probably act
synergistically to promote biofilm.
Figure 4 The fold change in the amount of uronic acid (capsule)
and biofilm produced by the Δcps and Δwzabc mutants relative
to the wild-type (WT). Error bars represent the standard deviation
of three biological replicates. The uronic acid data is identical to that
found in Figure 2 but presented here as fold change.
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In this study, we observed a complex interplay among
encapsulation, biofilm formation, and fimbriae expres-
sion in Klebsiella pneumoniae MGH 78578. This strain
exhibited increased biofilm formation despite the ab-
sence of capsule, an effect likely stemming from strong
up-regulation of the pga operon. In contrast, other
strains with different deletions within the capsule bio-
synthesis cluster have been reported to produce less bio-
film, not more [21,22,40]. It is not known, however, how
expression levels of the pga operon might have changed
in these other mutants. In addition, type 1 fimbriae have
been reported to play an important role in biofilm for-
mation in a non-encapsulated K. pneumoniae mutant
[23], but no fimbriae was necessary for increased biofilm
formation in the non-encapsulated mutant we generated
(Figure 3). Taken together, these observations suggest
that overlapping regulatory mechanisms likely act to
regulate these three features in K. pneumoniae in a
strain-specific manner.Additional files
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